PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Clinical evidence
L. multiflora demonstrated antiepileptic and anti-inflammatory effects in mice models induced by pilocarpine [PMID:39498072]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 35265846 (2022) — Approaches for the Elimination of Microbial Contaminants from Lippia multiflora Mold. Leaves Intended for Tea Bagging and Evaluation of Formulation. · Advances in pharmacological and pharmaceutical sciences
- 2.PMID: 40649396 (2025) — Phytochemical Screening and Biological Activities of Lippia multiflora Moldenke. · Molecules (Basel, Switzerland)
- 3.PMID: 39498072 (2024) — Antiepileptic and anti-inflammatory effects of Lippia multiflora moldenke (Verbenaceae) in mice model of chronic temporal lobe epilepsy induced by pilocarpine. · Heliyon